Navigation Links
Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
Date:5/21/2008

nefits.

Investor Q&A Session

United Therapeutics will host an investor Q&A session following the conclusion of the ATS conference at The Westin Harbour Castle, One Harbour Square, Toronto, Ontario, on May 21, 2008, at 5:00 pm EDT. Vallerie McLaughlin, MD, Director of the Pulmonary Hypertension Program at the University of Michigan, will join United Therapeutics' senior management in this Q&A session, which is also being webcast and can be accessed via United Therapeutics' website at http://ir.unither.com/events.cfm.

About Remodulin

Remodulin is indicated for the treatment of PAH in patients with NYHA Class II-IV symptoms to diminish symptoms associated with exercise. It may be administered as a continuous subcutaneous infusion or continuous intravenous infusion; however, because of the risks associated with chronic indwelling central venous catheters, including serious blood stream infections, continuous intravenous infusion should be reserved for patients who are intolerant of the subcutaneous route, or in whom these risks are considered warranted.

Remodulin is indicated to diminish the rate of clinical deterioration in patients requiring transition from Flolan(R); the risks and benefits of each drug should be carefully considered prior to transition.

Important Safety Information

Chronic intravenous infusions of Remodulin are delivered using an indwelling central venous catheter. This route is associated with the risk of blood stream infections (BSI) and sepsis, which may be fatal. Remodulin is contraindicated in patients with hypersensitivity to Remodulin, its ingredients, or similar drugs. Remodulin is a potent vasodilator. It lowers blood pressure, which may be further lowered by other drugs that also reduce blood pressure. Remodulin inhibits platelet aggregation and therefore, may increase the risk of bleeding, particularly in patients on anticoagulants
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Treprostinil Data to be Presented at Annual Meeting of the American Thoracic Society
2. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
3. Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
4. New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nations Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
5. Eisais Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
6. New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
7. XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
8. Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
9. Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting
10. Data from Randomized Pilot Study, Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008
11. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... PITTSBURGH , July 30, 2014   ... Markets Groups Inc.: OTC Pink: UPZS), a Delaware ... a distribution agreement with Larasan Pharmaceutical Corporation ("Larasan"), a ... products.  According to the agreement, US-based Larasan will ... gourmet 6" frozen pizza through Larasan,s vast distribution ...
(Date:7/30/2014)... Germany , July 30, 2014  invendo medical ... computer-assisted ("robotic") colonoscopy system, today announced the appointment of ... device executive, as a new member of its supervisory ... respected global visionary in the medical device industry. In ... Chief Executive Officer at Given Imaging Ltd. (NASDAQ/TASE: GIVN), ...
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron ... (EURONEXT: SAN and NYSE: SNY ) today ... alirocumab in people with hypercholesterolemia met their primary efficacy ... low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to ... antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
Breaking Medicine Technology:Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8
... LIUZHOU CITY, China , July 19 ... CNBI), ("China BCT" or the,"Company"), a leading pharmaceutical distributor, ... Province , China , today,announced that on ... Public,Accountants, A Professional Corporation, Glendale, California ("PKF,California"), ...
... 19 "This is a historic day for HIV prevention research. ... gel can help to prevent sexual transmission of HIV infection," said AVAC ... landmark microbicide trial presented today at the International AIDS Conference in ... "We believe ...
Cached Medicine Technology:China BCT Announces Auditor Change Within PKF Network 2China BCT Announces Auditor Change Within PKF Network 3AVAC Praises CAPRISA 004 Trial Collaborators and Participants for Historic Study - Trial Confirms Promise of ARV-Based Microbicides 2AVAC Praises CAPRISA 004 Trial Collaborators and Participants for Historic Study - Trial Confirms Promise of ARV-Based Microbicides 3AVAC Praises CAPRISA 004 Trial Collaborators and Participants for Historic Study - Trial Confirms Promise of ARV-Based Microbicides 4
(Date:7/30/2014)... Daily Gossip indicates in its 60 Second Panic ... attack is a feeling of intense stress and fear, which ... of symptoms that sufferers commonly deal with when panic attacks ... or anxiety. Naturally, panic attacks deeply affect lifestyle; this is ... them. , The 60 Second Panic Solution review promises to ...
(Date:7/30/2014)... July 30, 2014 The Restore My Blood ... from high blood sugar levels can now find an amazingly ... The new program was created by D. Chao and Andrew ... beneficial for patients when it comes to normalizing blood sugar ... there is a secret to the cure of diabetes that ...
(Date:7/30/2014)... weeks freshman will begin to pour onto college campuses, each student ... time of growth and the start to something big. Statistically speaking, ... as easy as it looks. Some sources cite as ... once and many will switch two or three times. Each switch ... switching in the later years of college. According to the ...
(Date:7/30/2014)... 30, 2014 Ticket Down is ... Munich vs. Chivas Guadalajara friendly exhibition match at the ... Cup, the one team that was left standing as the ... it through the world’s largest football competition and even embarrassed ... way to the cup. Germany was led by seven players ...
(Date:7/30/2014)... HealthDay Reporter WEDNESDAY, July 30, ... likely to develop dementia, but researchers have been unable to ... Specifically, they haven,t been able to figure out the ... bring on dementia, or does dementia cause people to become ... the journal Neurology sheds more light on the ...
Breaking Medicine News(10 mins):Health News:60 Second Panic Solution Review Reveals Unique Way to Stop Panic Attacks 2Health News:Restore My Blood Sugar Review Reveals Exclusive Ways to Normalize Blood Sugar 2Health News:Advice to College Freshman from Author Garrett Miller 2Health News:Advice to College Freshman from Author Garrett Miller 3Health News:Bayern Munich vs. Chivas Guadalajara Tickets Red Bull Arena: Ticket Down Slashes Ticket Prices for Chivas Guadalajara vs. Bayern Munich in Harrison, NJ 2Health News:Bayern Munich vs. Chivas Guadalajara Tickets Red Bull Arena: Ticket Down Slashes Ticket Prices for Chivas Guadalajara vs. Bayern Munich in Harrison, NJ 3Health News:Scientists Shed Light on Link Between Depression, Dementia 2Health News:Scientists Shed Light on Link Between Depression, Dementia 3
... OMCL ), a leading provider of system solutions to acute healthcare,facilities, will ... 2008 financial results., What: Omnicell second quarter ... 21, 2008, 1:30 p.m. PDT Who: Randall ... Rob Seim, chief financial officer Where: ...
... developing brain,s ability to make neural connections , , THURSDAY, ... affect brain development may be shared by the many ... new report shows. , The findings, published in the ... large sections missing on chromosomes in autistic people that ...
... Care Education and Updates for Kidney Dialysis Benefit, ... the,passage of the Medicare bill (H.R. 6331) yesterday, ... advocates, dialysis professionals, care,providers and manufacturers working together ... disease and kidney failure -- applauded the United,States ...
... The following is a,statement by Mark J. Feldman, ... that 70 percent of the U.S. population now ... encouraging news from the Centers for Disease,Control and ... Americans,receiving optimally fluoridated water. We know from years ...
... Healthcare and Educate Patients, SAN FRANCISCO ... Inc. and,Iverson Genetic Diagnostics, Inc. today announced ... reports for individuals receiving,Iverson,s molecular-based assay for ... DNA Direct will provide a customized,web-enabled tool ...
... the United States, List of ... Fur-Free Retailers and Designers to 100, SALT LAKE CITY, ... giant Overstock.com, Inc. (Nasdaq: OSTK ),and The Humane Society ... online that contain animal fur effective today. With,annual revenues exceeding ...
Cached Medicine News:Health News:Omnicell to Release Second Quarter 2008 Earnings Results on July 21 2Health News:Common Mechanisms May Contribute to Autism's Mutations 2Health News:Kidney Community Applauds Senate for Passage of End Stage Renal Disease (ESRD) Improvements 2Health News:DNA Direct and Iverson Genetics Announce Partnership to Provide Personalized Patient Reports for Warfarin Dosing Test Results 2Health News:DNA Direct and Iverson Genetics Announce Partnership to Provide Personalized Patient Reports for Warfarin Dosing Test Results 3Health News:Overstock.com Goes Fur Free 2Health News:Overstock.com Goes Fur Free 3
InterVascular HemaCarotid Patch product line offers the vascular surgeon a complete range of knitted, collagen coated patches in a wide range of sizes for carotid endarterectomy and angioplasty witho...
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
D-Stat Radial is a dry version of the D-Stat together with a compression band, and is designed for the control of surface bleeding from vascular access sites, including the sites on the radial artery...
Medicine Products: